In vivo, they effectively reduced tumor size in MDA-MB-231 xenograft models, accompanied by increased cytokine levels (IL-2, IL-6, TNF-α, IFN-γ) and many CD3+ cells. The gene discussed is TNF; the disease is neoplasm.